We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Andrx, Schering Settle Claritin-D Patent Dispute

Law360 (October 24, 2003, 12:00 AM EDT) -- Andrx Corp. settled a patent dispute with Schering-Plough Corp. over Andrx's generic version of the Claritin-D 24-hour allergy medicine, the companies said Friday.

Andrx will receive a license to a patent...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.